143.63

0.23% -0.33

After Hours: 143.63

Davita Inc (DVA)

Overview News Price History Option Chain Financials Why DVA Down? Discussions Forecast Stock Split

Davita Inc stock is traded at $143.63, with a volume of 569.39K. It is down -0.23% in the last 24 hours and down -0.20% over the past month. DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.

Previous Close:

$143.96

Open:

$144

24h Volume:

569.39K

Relative Volume:

0.60

Market Cap:

$12.58B

Revenue:

$12.67B

Net Income/Loss:

$827.68M

P/E Ratio:

15.49

EPS:

9.27

Net Cash Flow:

$1.42B

1W Performance:

+2.27%

1M Performance:

-0.20%

6M Performance:

-4.03%

1Y Performance:

+5.73%

1-Day Range:

$142.80

$145.80

1-Week Range:

$139.35

$145.80

52-Week Range:

$131.44

$179.60

Davita Inc Stock (DVA) Company Profile

Name

Davita Inc

Sector

Healthcare (1153)

Industry

Medical Care Facilities (59)

Phone

310-536-2668

Address

2000 16TH STREET, DENVER, CO

Employee

70,000

Twitter

@DaVita

Next Earnings Date

2024-10-29

Latest SEC Filings

DVA's Discussions on Twitter

Compare DVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DVA Davita Inc	143.63	12.58B	12.67B	827.68M	1.42B	9.27
HCA Hca Healthcare Inc	353.92	82.53B	71.59B	5.78B	4.95B	22.49
FMS Fresenius Medical Care Ag Adr	28.07	16.47B	20.87B	715.14M	1.67B	1.2209
EHC Encompass Health Corp	115.91	11.69B	5.22B	422.40M	269.50M	4.14
THC Tenet Healthcare Corp	149.06	11.51B	20.97B	3.13B	2.39B	31.21

Davita Inc Stock (DVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-06-24	Initiated	Barclays	Equal Weight
Aug-07-23	Upgrade	UBS	Neutral → Buy
Nov-01-22	Downgrade	Deutsche Bank	Buy → Hold
Oct-31-22	Downgrade	UBS	Buy → Neutral
Aug-19-22	Resumed	UBS	Buy
Jun-21-22	Reiterated	BofA Securities	Underperform
Sep-10-21	Initiated	Cowen	Market Perform
Aug-12-21	Downgrade	Barclays	Overweight → Equal Weight
Mar-26-21	Downgrade	BofA Securities	Neutral → Underperform
Jan-05-21	Downgrade	BofA Securities	Buy → Neutral
Jan-24-20	Upgrade	Goldman	Neutral → Buy
Nov-07-19	Downgrade	Raymond James	Outperform → Mkt Perform
Oct-25-19	Downgrade	Wolfe Research	Outperform → Peer Perform
Sep-11-19	Downgrade	William Blair	Outperform → Mkt Perform
Jul-26-19	Downgrade	Robert W. Baird	Outperform → Neutral
Jan-08-19	Upgrade	UBS	Sell → Neutral
Jan-03-19	Initiated	Deutsche Bank	Buy
Dec-14-18	Initiated	Barclays	Overweight
Nov-28-18	Upgrade	Raymond James	Mkt Perform → Outperform
Nov-16-18	Initiated	UBS	Sell
Nov-08-18	Downgrade	Raymond James	Strong Buy → Mkt Perform
Sep-13-18	Upgrade	JP Morgan	Underweight → Neutral
Jan-04-18	Upgrade	BofA/Merrill	Neutral → Buy
Dec-12-17	Upgrade	Robert W. Baird	Neutral → Outperform
Dec-11-17	Upgrade	Citigroup	Neutral → Buy
Dec-07-17	Upgrade	Raymond James	Outperform → Strong Buy
Nov-08-17	Reiterated	RBC Capital Mkts	Sector Perform
Oct-09-17	Downgrade	JP Morgan	Neutral → Underweight
Jun-26-17	Downgrade	Jefferies	Buy → Hold
Dec-13-16	Downgrade	Robert W. Baird	Outperform → Neutral